Shorts

Proving safety in new drug trials.

The Dangers of Decreasing Injection Frequency Too Fast

Is oral minoxidil safe for hair loss?

AI Models May Improve Risk Prediction in Early-Stage Melanoma

Lasers and DNA: How skin treatments impact cancer biology

A New Way to Treat Atopic Dermatitis?

Stop Using the Word 'Robust' in Dermatology

We Found a Way to Reverse Skin Aging at the Cellular Level

Prioritizing Skin Health Checks for Patients of All Skin Tones

The Only UV Safety Advice You Need This July

Why Patient Stratification Matters in Clinical Trials

The Importance of Early PsA Treatment for Joint Health

Why Your Acne Treatments May Not Be Working

Why patients are moving away from injectable psoriasis treatments

A Win for Patients and Providers: Roflumilast’s Expanded PsO Indication

Roflumilast Cream Approved for Children as Young as 2 With Plaque Psoriasis

Rethinking First-Line Treatment for Atopic Dermatitis

What AbbVie’s Acquisition of Apogee Means for AD Treatment

When Patients Fear Their AD Medication

The Myths Surrounding Food Allergies and Atopic Dermatitis

Why Chronic Hand Eczema is More Than Just an Itch

Why Individualized Care Matters in the Age of "Preventative Botox"

Expanding Access and Promoting Purpose in Dermatology

How to Stop Patients from Following Unsafe Skin Care Trends

Bimatrizinol Becomes First New US Sunscreen Ingredient in 20 Years

Showing Patients Evidence of Sun Damage

Afamelanotide That Boosts Skin Photoprotection

Why Not All Microneedling Pens Are The Same

Resources for Clinicians From the Melanoma Research Foundation

Soquelitinib May Offer New Oral Treatment for Patients With AD